Search results for "Aortic Valve Stenosis"

showing 10 items of 60 documents

A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aorti…

2016

Aims Our aim was to assess the clinical outcomes of the Direct Flow Medical Transcatheter Aortic Valve System (DFM-TAVS), when used in routine clinical practice. Methods and results This is a prospective, open-label, multicentre, post-market registry of patients treated with DFM-TAVS according to approved commercial indications. Echocardiographic and angiographic data were evaluated by an independent core laboratory and adverse events were adjudicated and classified according to VARC-2 criteria by an independent clinical events committee. The primary endpoint was freedom from all-cause mortality at 30 days post procedure. Secondary endpoints included procedural, early safety and efficacy en…

Aortic valveMalemedicine.medical_specialtyCardiac Catheterizationmedicine.medical_treatmentAortic Valve InsufficiencyRegurgitation (circulation)030204 cardiovascular system & hematologyTranscatheter Aortic Valve Replacement03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineClinical endpointHumans030212 general & internal medicineHeart valveProspective StudiesRegistriesCardiac catheterizationAgedAged 80 and overHeart Valve Prosthesis Implantationbusiness.industryAortic Valve Stenosismedicine.disease3. Good healthClinical trialStenosismedicine.anatomical_structureTreatment OutcomeAortic valve stenosisAortic ValveHeart Valve ProsthesisCardiologyFemaleCardiology and Cardiovascular MedicinebusinessEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
researchProduct

Incidence, Predictive Factors, and Prognostic Impact of Silent Atrial Fibrillation After Transcatheter Aortic Valve Implantation.

2018

New onset atrial fibrillation post-transcatheter aortic valve implantation (TAVI) is common and is associated with adverse outcomes. However, silent atrial fibrillation (AF) is poorly documented in the context. This study sought to evaluate the incidence, predictive factors, and prognostic value of Silent AF post-TAVI. All the consecutive patients with TAVI were prospectively analyzed by continuous electrocardiogram monitoring≥48 hours after implantation. Silent AF was defined as asymptomatic episodes lasting at least 30 seconds. The population was divided into 3 groups: history of AF, no-AF, and silent AF. Among the 206 patients implanted with TAVI, 19 (16.1%) developed silent AF. Compared…

Aortic valveMalemedicine.medical_specialtyTime FactorsPopulationContext (language use)030204 cardiovascular system & hematologyAsymptomaticTranscatheter Aortic Valve Replacement03 medical and health sciencesElectrocardiography0302 clinical medicinePostoperative ComplicationsRisk FactorsInternal medicineAtrial FibrillationmedicineHumans030212 general & internal medicineProspective StudiesRegistriesProspective cohort studyeducationAged 80 and overeducation.field_of_studymedicine.diagnostic_testbusiness.industryIncidenceAtrial fibrillationAortic Valve Stenosismedicine.diseasePrognosismedicine.anatomical_structureAortic valve stenosisAortic ValveCardiologyFemaleFrancemedicine.symptomCardiology and Cardiovascular MedicinebusinessElectrocardiographyFollow-Up StudiesThe American journal of cardiology
researchProduct

Echocardiographic and angiographic evaluation of left ventricular function during percutaneous transluminal aortic valvuloplasty.

1992

Transesophageal echocardiography was used to study the effect of the balloon inflation on left ventricular function in 20 patients with critical aortic stenosis undergoing balloon valvuloplasty. Balloon inflation caused an increase of end-diastolic (15% to 34%) and end-systolic (57% to 72%) left ventricular volume. Left ventricular wall stress increased from 30 +/- 10 x 10(3) dyn/cm2 at diastole and 121 +/- 40 x 10(3) dyn/cm2 at systole to 44 +/- 11 x 10(3) dyn/cm2 and 191 +/- 55 x 10(3) dyn/cm2, respectively, when the balloon was inflated (P less than 0.05). Turbulent regurgitant jet across the mitral valve increased from 15 +/- 2% to 25 +/- 3% during balloon inflation (P less than 0.01). …

Aortic valveMalemedicine.medical_specialtymedicine.medical_treatmentDiastoleMyocardial InfarctionBalloonCoronary AngiographyVentricular Function LeftCatheterizationRisk FactorsMitral valveInternal medicineCoronary CirculationmedicineHumansSystoleCardiac OutputAgedAged 80 and overbusiness.industryHemodynamicsMitral Valve InsufficiencyBlood flowAortic Valve StenosisMiddle Agedmedicine.diseaseAortic valvuloplastyStenosismedicine.anatomical_structureEchocardiographyAortic Valvecardiovascular systemCardiologyFemaleCardiology and Cardiovascular MedicinebusinessCatheterization and cardiovascular diagnosis
researchProduct

On the Left Ventricular Remodeling of Patients with Stenotic Aortic Valve: A Statistical Shape Analysis

2021

The left ventricle (LV) constantly changes its shape and function as a response to pathological conditions, and this process is known as remodeling. In the presence of aortic stenosis (AS), the degenerative process is not limited to the aortic valve but also involves the remodeling of LV. Statistical shape analysis (SSA) offers a powerful tool for the visualization and quantification of the geometrical and functional patterns of any anatomic changes. In this paper, a SSA method was developed to determine shape descriptors of the LV under different degrees of AS and thus to shed light on the mechanistic link between shape and function. A total of n=86 patients underwent computed tomography (…

Aortic valveTechnologymedicine.medical_specialtyQH301-705.5left ventricle0206 medical engineeringstatistical shape analysisBioengineeringaortic valve stenosis02 engineering and technology030204 cardiovascular system & hematologyArticle03 medical and health sciences0302 clinical medicineInternal medicinemedicineIn patientBiology (General)Settore ING-IND/15 - Disegno E Metodi Dell'Ingegneria IndustrialeVentricular remodelingbusiness.industryTStatistical shape analysisSettore ING-IND/34 - Bioingegneria IndustrialeBaseline modelmedicine.disease020601 biomedical engineeringStenosismedicine.anatomical_structureAortic valve stenosis Left ventricle Statistical shape analysisVentriclePrincipal component analysisCardiologybusinessBioengineering
researchProduct

TAVI imaging: over the echocardiography

2020

Aortic valve stenosis (AS) is a common valvular heart disease. Recently, transcatheter aortic valve implantation (TAVI) has changed the treatment of severe AS in elderly patients with contraindications to traditional surgical replacement. Echocardiography is conventionally used as the first imaging modality to assess the presence and severity of AS and to provide anatomical and functional information. Nowadays, imaging techniques play a crucial role in the planning of TAVI to define suitable candidates. Computed tomography (CT) is essential to display the anatomy of the aortic valve complex (including aortic annulus, Valsalva sinuses, coronary arteries ostia, sinotubular junction), thoracoa…

Aortic valvemedicine.medical_specialtyAortic valve stenosisCoronary Angiography030218 nuclear medicine & medical imagingTranscatheter Aortic Valve Replacement03 medical and health sciences0302 clinical medicineMagnetic resonance imagingmedicineHumansRadiology Nuclear Medicine and imagingCardiac skeletonComputed tomographyNeuroradiologyAgedIncidental FindingsTranscatheter aortic valve implantationmedicine.diagnostic_testbusiness.industryvalvular heart diseaseSettore ING-IND/34 - Bioingegneria IndustrialeMagnetic resonance imagingInterventional radiologyGeneral Medicinemedicine.diseaseCoronary arteriesmedicine.anatomical_structureEchocardiography030220 oncology & carcinogenesisAortic valve stenosiscardiovascular systemRadiologybusinessTomography X-Ray ComputedSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

Bicuspid aortic valve and sports: From the echocardiographic evaluation to the eligibility for sports competition

2021

Bicuspid aortic valve (BAV) is the most common congenital heart defect in adults. Although a BAV may remain without clinical consequences for a lifetime, it can deteriorate in aortic valve stenosis and regurgitation and aortic dilatation. Unfortunately, the impact of regular training on patients with BAV and its natural course is not fully understood, although preliminary evidence suggests that the progression of valvular disease occurs primarily in an independent manner from sports practice. The current review aims to report how to perform a comprehensive echocardiographic examination in athletes with BAV and analyze the current literature on the influence of sports practice and how it imp…

Aortic valvemedicine.medical_specialtyCompetitive BehaviorEligibility DeterminationPhysical Therapy Sports Therapy and RehabilitationRegurgitation (circulation)030204 cardiovascular system & hematologyBicuspid Aortic Valve03 medical and health sciences0302 clinical medicineBicuspid aortic valveValvular diseaseBicuspid Aortic Valve DiseaseInternal medicinemedicineHumansOrthopedics and Sports MedicineEligibility DeterminationExerciseAortaAortic dilatationbiologybusiness.industryAthletes030229 sport sciencesbiology.organism_classificationmedicine.diseaseEchocardiography Dopplermedicine.anatomical_structureAortic valve stenosiscardiovascular systemCardiologybusinessDilatation PathologicPhysical Conditioning HumanSports
researchProduct

Assessment of left ventricular function during aortic balloon valvuloplasty by transesophageal echocardiography

1989

Several reports have documented the feasability and utility of balloon aortic valvuloplasty as a palliative treatment for high-surgical-risk patients with critical aortic valve stenosis (1–3).

Aortic valvemedicine.medical_specialtyMitral regurgitationVentricular functionPalliative treatmentbusiness.industrymedicine.medical_treatmentmedicine.diseaseBalloon valvuloplastyBalloonAortic valvuloplastymedicine.anatomical_structureAortic valve stenosisInternal medicinecardiovascular systemmedicineCardiologybusiness
researchProduct

Chronic atrial fibrillation in presence of aortic stenosis in a patient with polysplenia syndrome.

2013

We report a rare case of “situs viscerum ambiguous” with polysplenia syndrome, in a 69 year old female patient with aortic stenosis and chronic atrial fibrillation. The presenting symptom was dyspnoea on moderate exertion and an ECG showed supra ventricular arrhythmia. Patients trans-thoracic echocardiogram revealed a dilated left atrium, reduced ejection fraction, mild tricuspid regurgitation, moderate-severe pulmonary hypertension and severe aortic stenosis. The patient was successfully treated with a replacement of her aortic valve and ascending aorta.

Aortic valvemedicine.medical_specialtyPolysplenia syndromeRegurgitation (circulation)Heterotaxy SyndromePolysplenia Aortic Stenosis Atrial Fibrillationmedicine.arteryInternal medicineAscending aortaAtrial FibrillationMedicineChronic atrial fibrillationHumanscardiovascular diseasesAortaAgedHeart Valve Prosthesis ImplantationEjection fractionbusiness.industryGeneral MedicineAortic Valve Stenosismedicine.diseasePulmonary hypertensionSettore MED/11 - Malattie Dell'Apparato CardiovascolareStenosismedicine.anatomical_structureTreatment OutcomeChronic Diseasecardiovascular systemCardiologyFemalebusinessActa clinica Belgica
researchProduct

2016

Background Transcatheter aortic valve implantation (TAVI) has become the treatment of choice in patients with severe aortic valve stenosis who are not eligible for operative replacement and an alternative for those with high surgical risk. Due to high age and smoking history in a high proportion of TAVI patients, suspicious findings are frequently observed in pre-procedural chest computer tomography (CCT).

Aortic valvemedicine.medical_specialtySolitary pulmonary noduleMultidisciplinarybusiness.industryPleural effusionIncidence (epidemiology)Stroke volume030204 cardiovascular system & hematologymedicine.diseaseSurgery03 medical and health sciencesStenosis0302 clinical medicinemedicine.anatomical_structureAortic valve stenosisMedicine030212 general & internal medicineRadiologybusinessThoracic NeoplasmPLOS ONE
researchProduct

Sex-based differences in outcomes with bivalirudin or unfractionated heparin for transcatheter aortic valve replacement: Results from the BRAVO-3 ran…

2016

Background Women comprise almost 50% of patients undergoing transcatheter aortic valve replacement (TAVR) and previous studies have indicated higher rates of procedural complications and bleeding in women compared to men. It is unknown whether men and women demonstrate a differential response to bivalirudin versus unfractionated heparin (UFH) in TAVR. We sought to evaluate outcomes by sex and type of anticoagulant from the Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement (BRAVO-3) trial of transfemoral TAVR. Methods BRAVO-3 was a randomized multicenter trial comparing transfemoral TAVR with bivalirudin versus UFH (31 centers, n = 802). The primary endpoin…

Aortic valvemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatment030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineValve replacementInternal medicineMulticenter trialmedicineBivalirudinRadiology Nuclear Medicine and imaging030212 general & internal medicinebusiness.industryAnticoagulantEuroSCOREGeneral Medicinemedicine.diseasemedicine.anatomical_structureAortic valve stenosisCardiologyCardiology and Cardiovascular MedicinebusinessMacemedicine.drugCatheterization and Cardiovascular Interventions
researchProduct